{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:43Z","timestamp":1792783423474,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hunan Science Fund for Distinguished Young Scholars","award":["2024JJ2091"],"award-info":[{"award-number":["2024JJ2091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05464-6","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:19:10Z","timestamp":1764051550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beyond mTOR: Unraveling the Complex Pathophysiology and Signaling Pathways in Focal Cortical Dysplasia"],"prefix":"10.1007","volume":"63","author":[{"given":"Kang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxing","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"4","key":"5464_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/jnnp.34.4.369","volume":"34","author":"DC Taylor","year":"1971","unstructured":"Taylor DC, Falconer MA, Bruton CJ, Corsellis JA (1971) Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34(4):369\u2013387. https:\/\/doi.org\/10.1136\/jnnp.34.4.369","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5464_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ana.410440507","volume":"44","author":"E Wyllie","year":"1998","unstructured":"Wyllie E, Comair YG, Kotagal P, Bulacio J, Bingaman W, Ruggieri P (1998) Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 44(5):740\u2013748. https:\/\/doi.org\/10.1002\/ana.410440507","journal-title":"Ann Neurol"},{"key":"5464_CR3","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1056\/NEJMoa1703784","volume":"377","author":"I Blumcke","year":"2017","unstructured":"Blumcke I et al (2017) Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 377:1648\u20131656. https:\/\/doi.org\/10.1056\/NEJMoa1703784","journal-title":"N Engl J Med"},{"key":"5464_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/brain\/aws019","volume":"135","author":"AJ Barkovich","year":"2012","unstructured":"Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB (2012) A developmental and genetic classification for malformations of cortical development: update 2012. Brain 135:1348\u20131369. https:\/\/doi.org\/10.1093\/brain\/aws019","journal-title":"Brain"},{"key":"5464_CR5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/brain\/awv045","volume":"138","author":"LA Jansen","year":"2015","unstructured":"Jansen LA et al (2015) PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138:1613\u20131628. https:\/\/doi.org\/10.1093\/brain\/awv045","journal-title":"Brain"},{"key":"5464_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"5464_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/jci73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125:25\u201332. https:\/\/doi.org\/10.1172\/jci73939","journal-title":"J Clin Invest"},{"key":"5464_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051544","author":"F LiCausi","year":"2018","unstructured":"LiCausi F, Hartman NW (2018) Role of mTOR complexes in neurogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051544","journal-title":"Int J Mol Sci"},{"key":"5464_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082226","author":"L Ryskalin","year":"2018","unstructured":"Ryskalin L, Limanaqi F, Frati A, Busceti CL, Fornai F (2018) mTOR-related brain dysfunctions in neuropsychiatric disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19082226","journal-title":"Int J Mol Sci"},{"key":"5464_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/epi.12650","volume":"55","author":"I Marin-Valencia","year":"2014","unstructured":"Marin-Valencia I, Guerrini R, Gleeson JG (2014) Pathogenetic mechanisms of focal cortical dysplasia. Epilepsia 55:970\u2013978. https:\/\/doi.org\/10.1111\/epi.12650","journal-title":"Epilepsia"},{"issue":"4","key":"5464_CR11","doi-asserted-by":"publisher","DOI":"10.3171\/2022.7.Focus21731","volume":"53","author":"O Kapar","year":"2022","unstructured":"Kapar O, Gurkan ZM, Dolgun M, Sencer A, G\u00fcrses C, Bilgic B (2022) Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis. Neurosurg Focus 53(4):E6. https:\/\/doi.org\/10.3171\/2022.7.Focus21731","journal-title":"Neurosurg Focus"},{"key":"5464_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025924","author":"DW Lamming","year":"2016","unstructured":"Lamming DW (2016) Inhibition of the mechanistic target of rapamycin (mTOR)-rapamycin and beyond. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a025924","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5464_CR13","doi-asserted-by":"publisher","unstructured":"Veersema TJ et al. (2019) Cognitive functioning after epilepsy surgery in children with mild malformation of cortical development and focal cortical dysplasia. Epilepsy Behav 94:209\u2013215. https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.009","DOI":"10.1016\/j.yebeh.2019.03.009"},{"key":"5464_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107990","volume":"120","author":"A Fujimoto","year":"2021","unstructured":"Fujimoto A et al (2021) Epilepsy in patients with focal cortical dysplasia may be associated with autism spectrum disorder. Epilepsy Behav 120:107990. https:\/\/doi.org\/10.1016\/j.yebeh.2021.107990","journal-title":"Epilepsy Behav"},{"key":"5464_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-pathmechdis-012418-012927","volume":"14","author":"G Juric-Sekhar","year":"2019","unstructured":"Juric-Sekhar G, Hevner RF (2019) Malformations of cerebral cortex development: molecules and mechanisms. Annu Rev Pathol 14:293\u2013318. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012927","journal-title":"Annu Rev Pathol"},{"key":"5464_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","volume":"52","author":"I Bl\u00fcmcke","year":"2011","unstructured":"Bl\u00fcmcke I et al (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158\u2013174. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02777.x","journal-title":"Epilepsia"},{"key":"5464_CR17","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/epi.17301","volume":"63","author":"I Najm","year":"2022","unstructured":"Najm I et al (2022) The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 63:1899\u20131919. https:\/\/doi.org\/10.1111\/epi.17301","journal-title":"Epilepsia"},{"key":"5464_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s12264-022-00828-7","volume":"38","author":"Y Shao","year":"2022","unstructured":"Shao Y et al (2022) Pathological networks involving dysmorphic neurons in type II focal cortical dysplasia. Neurosci Bull 38:1007\u20131024. https:\/\/doi.org\/10.1007\/s12264-022-00828-7","journal-title":"Neurosci Bull"},{"key":"5464_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/brain\/awaa387","volume":"144","author":"L Rossini","year":"2021","unstructured":"Rossini L et al (2021) Dendritic pathology, spine loss and synaptic reorganization in human cortex from epilepsy patients. Brain 144:251\u2013265. https:\/\/doi.org\/10.1093\/brain\/awaa387","journal-title":"Brain"},{"key":"5464_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/01.wnl.0000044053.09023.91","volume":"60","author":"MT Mackay","year":"2003","unstructured":"Mackay MT et al (2003) Malformations of cortical development with balloon cells: clinical and radiologic correlates. Neurology 60:580\u2013587. https:\/\/doi.org\/10.1212\/01.wnl.0000044053.09023.91","journal-title":"Neurology"},{"key":"5464_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1528-1167.2008.01682.x","volume":"50","author":"P Krsek","year":"2009","unstructured":"Krsek P et al (2009) Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 50:125\u2013137. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01682.x","journal-title":"Epilepsia"},{"key":"5464_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1528-1167.2011.03363.x","volume":"53","author":"F Chassoux","year":"2012","unstructured":"Chassoux F et al (2012) Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia 53:349\u2013358. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03363.x","journal-title":"Epilepsia"},{"key":"5464_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13311-021-01049-y","volume":"18","author":"AM Goodman","year":"2021","unstructured":"Goodman AM, Szaflarski JP (2021) Recent advances in neuroimaging of epilepsy. Neurotherapeutics 18:811\u2013826. https:\/\/doi.org\/10.1007\/s13311-021-01049-y","journal-title":"Neurotherapeutics"},{"key":"5464_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/epi.13313","volume":"57","author":"A De Ciantis","year":"2016","unstructured":"De Ciantis A et al (2016) 7T MRI in focal epilepsy with unrevealing conventional field strength imaging. Epilepsia 57:445\u2013454. https:\/\/doi.org\/10.1111\/epi.13313","journal-title":"Epilepsia"},{"issue":"6","key":"5464_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ana.24407","volume":"77","author":"ZI Wang","year":"2015","unstructured":"Wang ZI, Jones SE, Jaisani Z, Najm IM, Prayson RA, Burgess RC, Krishnan B, Ristic A et al (2015) Voxel-based morphometric magnetic resonance imaging (MRI) postprocessing in MRI-negative epilepsies. Ann Neurol 77(6):1060\u20131075. https:\/\/doi.org\/10.1002\/ana.24407","journal-title":"Ann Neurol"},{"key":"5464_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424\u2013430. https:\/\/doi.org\/10.1038\/nature04869","journal-title":"Nature"},{"key":"5464_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","volume":"493","author":"SC Johnson","year":"2013","unstructured":"Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493:338\u2013345. https:\/\/doi.org\/10.1038\/nature11861","journal-title":"Nature"},{"issue":"1","key":"5464_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev-pathol-052016-100138","volume":"12","author":"PH Iffland","year":"2017","unstructured":"Iffland PH, Crino PB (2017) Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol 12(1):547\u2013571. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100138","journal-title":"Annu Rev Pathol"},{"key":"5464_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18148","author":"M Sanders","year":"2024","unstructured":"Sanders M et al (2024) Somatic variant analysis of resected brain tissue in epilepsy surgery patients. Epilepsia. https:\/\/doi.org\/10.1111\/epi.18148","journal-title":"Epilepsia"},{"key":"5464_CR30","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s13311-021-01122-6","volume":"18","author":"AM D\u2019Gama","year":"2021","unstructured":"D\u2019Gama AM, Poduri A (2021) Precision therapy for epilepsy related to brain malformations. Neurotherapeutics 18:1548\u20131563. https:\/\/doi.org\/10.1007\/s13311-021-01122-6","journal-title":"Neurotherapeutics"},{"key":"5464_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19:373\u2013379. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001","journal-title":"Cell Metab"},{"key":"5464_CR32","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1172\/jci64099","volume":"123","author":"DW Lamming","year":"2013","unstructured":"Lamming DW, Ye L, Sabatini DM, Baur JA (2013) Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 123:980\u2013989. https:\/\/doi.org\/10.1172\/jci64099","journal-title":"J Clin Invest"},{"issue":"11","key":"5464_CR33","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1528-1167.2011.03272.x","volume":"52","author":"L D\u2019Argenzio","year":"2011","unstructured":"D\u2019Argenzio L, Colonnelli MC, Harrison S, Jacques TS, Harkness W, Vargha-Khadem F, Scott RC, Cross JH (2011) Cognitive outcome after extratemporal epilepsy surgery in childhood. Epilepsia 52(11):1966\u20131972. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03272.x","journal-title":"Epilepsia"},{"key":"5464_CR34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1212\/WNL.0b013e3182a1aa2a","volume":"81","author":"B Korman","year":"2013","unstructured":"Korman B et al (2013) Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks. Neurology 81:745\u2013751. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a1aa2a","journal-title":"Neurology"},{"key":"5464_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/neuros\/nyx340","volume":"83","author":"G Ramantani","year":"2018","unstructured":"Ramantani G et al (2018) Frontal lobe epilepsy surgery in childhood and adolescence: predictors of long-term seizure freedom, overall cognitive and adaptive functioning. Neurosurgery 83:93\u2013103. https:\/\/doi.org\/10.1093\/neuros\/nyx340","journal-title":"Neurosurgery"},{"key":"5464_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/acn3.51505","volume":"9","author":"M Kato","year":"2022","unstructured":"Kato M et al (2022) Sirolimus for epileptic seizures associated with focal cortical dysplasia type II. Ann Clin Transl Neurol 9:181\u2013192. https:\/\/doi.org\/10.1002\/acn3.51505","journal-title":"Ann Clin Transl Neurol"},{"key":"5464_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","volume":"4","author":"DA Krueger","year":"2017","unstructured":"Krueger DA et al (2017) Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders. Ann Clin Transl Neurol 4:877\u2013887. https:\/\/doi.org\/10.1002\/acn3.494","journal-title":"Ann Clin Transl Neurol"},{"key":"5464_CR38","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/wnl.0000000000007749","volume":"93","author":"IE Overwater","year":"2019","unstructured":"Overwater IE et al (2019) A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology 93:e200\u2013e209. https:\/\/doi.org\/10.1212\/wnl.0000000000007749","journal-title":"Neurology"},{"key":"5464_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70427","volume":"31","author":"Y He","year":"2025","unstructured":"He Y, Xie K, Yang K, Wang N, Zhang L (2025) Unraveling the interplay between metabolism and neurodevelopment in health and disease. CNS Neurosci Ther 31:e70427. https:\/\/doi.org\/10.1111\/cns.70427","journal-title":"CNS Neurosci Ther"},{"key":"5464_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8:455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z","journal-title":"Signal Transduct Target Ther"},{"key":"5464_CR41","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/aps.2017.197","volume":"39","author":"JJ Yao","year":"2018","unstructured":"Yao JJ, Zhao QR, Lu JM, Mei YA (2018) Functions and the related signaling pathways of the neurotrophic factor neuritin. Acta Pharmacol Sin 39:1414\u20131420. https:\/\/doi.org\/10.1038\/aps.2017.197","journal-title":"Acta Pharmacol Sin"},{"key":"5464_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/hsz-2015-0270","volume":"397","author":"J Zhong","year":"2016","unstructured":"Zhong J (2016) RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction. Biol Chem 397:215\u2013222. https:\/\/doi.org\/10.1515\/hsz-2015-0270","journal-title":"Biol Chem"},{"key":"5464_CR43","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/epi.17323","volume":"63","author":"TA Bedrosian","year":"2022","unstructured":"Bedrosian TA et al (2022) Detection of brain somatic variation in epilepsy-associated developmental lesions. Epilepsia 63:1981\u20131997. https:\/\/doi.org\/10.1111\/epi.17323","journal-title":"Epilepsia"},{"key":"5464_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pediatrneurol.2023.09.022","volume":"149","author":"Q Liu","year":"2023","unstructured":"Liu Q, Cai L, Sun Yu, Wang Y, Yu H, Liu C, Wang H, Zhang S, Gong J (2023) Epilepsy outcome and pathology analysis for ganglioglioma: a series of 51 pediatric patients. Pediatr Neurol 149:127\u2013133. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.09.022","journal-title":"Pediatr Neurol"},{"key":"5464_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/neup.12242","volume":"36","author":"VV Patil","year":"2016","unstructured":"Patil VV et al (2016) Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia. Neuropathology 36:146\u2013156. https:\/\/doi.org\/10.1111\/neup.12242","journal-title":"Neuropathology"},{"key":"5464_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuron.2014.09.009","volume":"84","author":"LB Zhang","year":"2014","unstructured":"Zhang LB et al (2014) MEK-ERK1\/2-dependent FLNA overexpression promotes abnormal dendritic patterning in tuberous sclerosis independent of mTOR. Neuron 84:78\u201391. https:\/\/doi.org\/10.1016\/j.neuron.2014.09.009","journal-title":"Neuron"},{"key":"5464_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2016.06.037","volume":"629","author":"LB Zhang","year":"2016","unstructured":"Zhang LB, Huang TX, Bordey A (2016) Haploinsufficiency is sufficient to increase dendritic patterning and Filamin A levels. Neurosci Lett 629:15\u201318. https:\/\/doi.org\/10.1016\/j.neulet.2016.06.037","journal-title":"Neurosci Lett"},{"key":"5464_CR48","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1245-23.2024","author":"MS Binder","year":"2024","unstructured":"Binder MS et al (2024) Reducing filamin A restores cortical synaptic connectivity and early social communication following cellular mosaicism in ASD pathways. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1245-23.2024","journal-title":"J Neurosci"},{"key":"5464_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf180","author":"L Zhang","year":"2025","unstructured":"Zhang L (2025) Filamin A in focus: unravelling the multifaceted roles of filamin A in neurodevelopment and neurological disorders. Brain. https:\/\/doi.org\/10.1093\/brain\/awaf180","journal-title":"Brain"},{"key":"5464_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pediatrneurol.2023.08.019","volume":"148","author":"G D\u2019Onofrio","year":"2023","unstructured":"D\u2019Onofrio G et al (2023) Treatment of refractory epilepsy with MEK inhibitor in patients with RASopathy. Pediatr Neurol 148:148\u2013151. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.08.019","journal-title":"Pediatr Neurol"},{"key":"5464_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2022.106890","volume":"181","author":"LH Nguyen","year":"2022","unstructured":"Nguyen LH, Leiser SC, Song D, Brunner D, Roberds SL, Wong M, Bordey A (2022) Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex. Epilepsy Res 181:106890. https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106890","journal-title":"Epilepsy Res"},{"key":"5464_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay0289","author":"L Zhang","year":"2020","unstructured":"Zhang L et al (2020) Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay0289","journal-title":"Sci Transl Med"},{"key":"5464_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainresbull.2020.11.023","volume":"168","author":"K Wu","year":"2021","unstructured":"Wu K et al (2021) Increased expression of fibroblast growth factor 13 in cortical lesions of the focal cortical dysplasia. Brain Res Bull 168:36\u201344. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.11.023","journal-title":"Brain Res Bull"},{"key":"5464_CR54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s11427-012-4412-x","volume":"55","author":"X Zhang","year":"2012","unstructured":"Zhang X, Bao L, Yang L, Wu Q, Li S (2012) Roles of intracellular fibroblast growth factors in neural development and functions. Sci China Life Sci 55:1038\u20131044. https:\/\/doi.org\/10.1007\/s11427-012-4412-x","journal-title":"Sci China Life Sci"},{"key":"5464_CR55","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.neuron.2011.08.002","volume":"71","author":"F Guillemot","year":"2011","unstructured":"Guillemot F, Zimmer C (2011) From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 71:574\u2013588. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.002","journal-title":"Neuron"},{"issue":"23","key":"5464_CR56","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1523\/jneurosci.3470-14.2015","volume":"35","author":"RS Puranam","year":"2015","unstructured":"Puranam RS, He XP, Yao L, Le T, Jang W, Rehder CW, Lewis DV, McNamara JO (2015) Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus. J Neurosci 35(23):8866\u20138881. https:\/\/doi.org\/10.1523\/jneurosci.3470-14.2015","journal-title":"J Neurosci"},{"key":"5464_CR57","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1074\/jbc.M110.159046","volume":"286","author":"A Carriere","year":"2011","unstructured":"Carriere A et al (2011) ERK1\/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem 286:567\u2013577. https:\/\/doi.org\/10.1074\/jbc.M110.159046","journal-title":"J Biol Chem"},{"key":"5464_CR58","doi-asserted-by":"publisher","unstructured":"Foster KG et al (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 285(1):80\u201394. https:\/\/doi.org\/10.1074\/jbc.M109.029637","DOI":"10.1074\/jbc.M109.029637"},{"key":"5464_CR59","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/0008-5472.Can-05-2925","volume":"66","author":"KE O\u2019Reilly","year":"2006","unstructured":"O\u2019Reilly KE et al (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66:1500\u20131508. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-2925","journal-title":"Cancer Res"},{"key":"5464_CR60","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016","journal-title":"Cell"},{"issue":"12","key":"5464_CR61","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1038\/s41593-024-01773-6","volume":"27","author":"N Matoba","year":"2024","unstructured":"Matoba N, Le BD, Valone JM, Wolter JM, Mory JT, Liang D, Ayg\u00fcn N, Broadaway KA et al (2024) Stimulating Wnt signaling reveals context-dependent genetic effects on gene regulation in primary human neural progenitors. Nat Neurosci 27(12):2430\u20132442. https:\/\/doi.org\/10.1038\/s41593-024-01773-6","journal-title":"Nat Neurosci"},{"key":"5464_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Ther"},{"key":"5464_CR63","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12883-023-03394-1","volume":"23","author":"DR Marinowic","year":"2023","unstructured":"Marinowic DR et al (2023) WNT pathway in focal cortical dysplasia compared to perilesional nonlesional tissue in refractory epilepsies. BMC Neurol 23:338. https:\/\/doi.org\/10.1186\/s12883-023-03394-1","journal-title":"BMC Neurol"},{"key":"5464_CR64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s004010051111","volume":"98","author":"D Cotter","year":"1999","unstructured":"Cotter D et al (1999) Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol 98:465\u2013472. https:\/\/doi.org\/10.1007\/s004010051111","journal-title":"Acta Neuropathol"},{"key":"5464_CR65","doi-asserted-by":"publisher","DOI":"10.1212\/nxg.0000000000000652","volume":"8","author":"MF Bennett","year":"2022","unstructured":"Bennett MF et al (2022) Evidence for a dual-pathway, 2-hit genetic model for focal cortical dysplasia and epilepsy. Neurol Genet 8:e652. https:\/\/doi.org\/10.1212\/nxg.0000000000000652","journal-title":"Neurol Genet"},{"issue":"2","key":"5464_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ydbio.2012.12.001","volume":"374","author":"J P\u00f6schl","year":"2013","unstructured":"P\u00f6schl J, Grammel D, Dorostkar MM, Kretzschmar HA, Sch\u00fcller U (2013) Constitutive activation of \u03b2-catenin in neural progenitors results in disrupted proliferation and migration of neurons within the central nervous system. Dev Biol 374(2):319\u2013332. https:\/\/doi.org\/10.1016\/j.ydbio.2012.12.001","journal-title":"Dev Biol"},{"key":"5464_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuron.2018.05.039","volume":"99","author":"SM Park","year":"2018","unstructured":"Park SM et al (2018) Brain somatic mutations in MTOR disrupt neuronal ciliogenesis, leading to focal cortical dyslamination. Neuron 99:83-97.e87. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.039","journal-title":"Neuron"},{"key":"5464_CR68","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1528-1167.2007.01055.x","volume":"48","author":"CL Busceti","year":"2007","unstructured":"Busceti CL et al (2007) Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia 48:694\u2013705. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01055.x","journal-title":"Epilepsia"},{"key":"5464_CR69","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature08356","volume":"461","author":"SM Huang","year":"2009","unstructured":"Huang SM et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614\u2013620. https:\/\/doi.org\/10.1038\/nature08356","journal-title":"Nature"},{"key":"5464_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eplepsyres.2018.07.002","volume":"146","author":"SL Hodges","year":"2018","unstructured":"Hodges SL, Lugo JN (2018) Wnt\/\u03b2-catenin signaling as a potential target for novel epilepsy therapies. Epilepsy Res 146:9\u201316. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.07.002","journal-title":"Epilepsy Res"},{"key":"5464_CR71","doi-asserted-by":"publisher","first-page":"20558","DOI":"10.1073\/pnas.0710156104","volume":"104","author":"JJ Breunig","year":"2007","unstructured":"Breunig JJ, Silbereis J, Vaccarino FM, Sestan N, Rakic P (2007) Notch regulates cell fate and dendrite morphology of newborn neurons in the postnatal dentate gyrus. Proc Natl Acad Sci U S A 104:20558\u201320563. https:\/\/doi.org\/10.1073\/pnas.0710156104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5464_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0896-6273(04)00182-5","volume":"42","author":"CA Saura","year":"2004","unstructured":"Saura CA et al (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42:23\u201336. https:\/\/doi.org\/10.1016\/s0896-6273(04)00182-5","journal-title":"Neuron"},{"key":"5464_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1593\/neo.131870","volume":"16","author":"S Zhang","year":"2014","unstructured":"Zhang S, Chung WC, Wu G, Egan SE, Xu K (2014) Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation. Neoplasia 16:158\u2013167. https:\/\/doi.org\/10.1593\/neo.131870","journal-title":"Neoplasia"},{"key":"5464_CR74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B et al (2022) Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther 7:95. https:\/\/doi.org\/10.1038\/s41392-022-00934-y","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5464_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijdevneu.2018.07.006","volume":"69","author":"F Majolo","year":"2018","unstructured":"Majolo F, Marinowic DR, Machado DC, Da Costa JC (2018) Notch signaling in human iPS-derived neuronal progenitor lines from focal cortical dysplasia patients. Int J Dev Neurosci 69(1):112\u2013118. https:\/\/doi.org\/10.1016\/j.ijdevneu.2018.07.006","journal-title":"Int J Dev Neurosci"},{"key":"5464_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuron.2008.02.014","volume":"58","author":"H Shimojo","year":"2008","unstructured":"Shimojo H, Ohtsuka T, Kageyama R (2008) Oscillations in notch signaling regulate maintenance of neural progenitors. Neuron 58:52\u201364. https:\/\/doi.org\/10.1016\/j.neuron.2008.02.014","journal-title":"Neuron"},{"key":"5464_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.devcel.2007.05.014","volume":"13","author":"G Bai","year":"2007","unstructured":"Bai G et al (2007) Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev Cell 13:283\u2013297. https:\/\/doi.org\/10.1016\/j.devcel.2007.05.014","journal-title":"Dev Cell"},{"key":"5464_CR78","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1126\/science.271.5257.1826","volume":"271","author":"JD Axelrod","year":"1996","unstructured":"Axelrod JD, Matsuno K, Artavanis-Tsakonas S, Perrimon N (1996) Interaction between Wingless and Notch signaling pathways mediated by dishevelled. Science 271:1826\u20131832. https:\/\/doi.org\/10.1126\/science.271.5257.1826","journal-title":"Science"},{"issue":"1","key":"5464_CR79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-pathol-031620-113409","volume":"16","author":"NE Propson","year":"2021","unstructured":"Propson NE, Gedam M, Zheng H (2021) Complement in neurologic disease. Annu Rev Pathol 16(1):277\u2013298. https:\/\/doi.org\/10.1146\/annurev-pathol-031620-113409","journal-title":"Annu Rev Pathol"},{"key":"5464_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102979","volume":"137","author":"SL Coss","year":"2023","unstructured":"Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP et al (2023) The complement system and human autoimmune diseases. J Autoimmun 137:102979. https:\/\/doi.org\/10.1016\/j.jaut.2022.102979","journal-title":"J Autoimmun"},{"issue":"3","key":"5464_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13141","volume":"33","author":"L Rossini","year":"2023","unstructured":"Rossini L, De Santis D, Cecchini E, Cagnoli C, Maderna E, Cartelli D, Morgan BP, Torvell M et al (2023) Dendritic spine loss in epileptogenic type II focal cortical dysplasia: role of enhanced classical complement pathway activation. Brain Pathol 33(3):e13141. https:\/\/doi.org\/10.1111\/bpa.13141","journal-title":"Brain Pathol"},{"key":"5464_CR82","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/nan.12736","volume":"47","author":"TS Zimmer","year":"2021","unstructured":"Zimmer TS et al (2021) Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol 47:826\u2013839. https:\/\/doi.org\/10.1111\/nan.12736","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5464_CR83","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1528-1167.2010.02547.x","volume":"51","author":"A Iyer","year":"2010","unstructured":"Iyer A et al (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51:1763\u20131773. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02547.x","journal-title":"Epilepsia"},{"key":"5464_CR84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/epi.17139","volume":"63","author":"VE Gruber","year":"2022","unstructured":"Gruber VE et al (2022) Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions. Epilepsia 63:364\u2013374. https:\/\/doi.org\/10.1111\/epi.17139","journal-title":"Epilepsia"},{"key":"5464_CR85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrn2286","volume":"9","author":"N Spruston","year":"2008","unstructured":"Spruston N (2008) Pyramidal neurons: dendritic structure and synaptic integration. Nat Rev Neurosci 9:206\u2013221. https:\/\/doi.org\/10.1038\/nrn2286","journal-title":"Nat Rev Neurosci"},{"key":"5464_CR86","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/15357597231218603","volume":"24","author":"S Kumari","year":"2024","unstructured":"Kumari S, Brewster AL (2024) Exploring dendritic and spine structural profiles in epilepsy: insights from human studies and experimental animal models. Epilepsy Curr 24:40\u201346. https:\/\/doi.org\/10.1177\/15357597231218603","journal-title":"Epilepsy Curr"},{"issue":"5","key":"5464_CR87","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1528-1167.2005.01021.x","volume":"46","author":"JP Leite","year":"2005","unstructured":"Leite JP, Neder L, Arisi GM, Carlotti CG Jr., Assirati JA, Moreira JE (2005) Plasticity, synaptic strength, and epilepsy: what can we learn from ultrastructural data? Epilepsia 46(5):134\u2013141. https:\/\/doi.org\/10.1111\/j.1528-1167.2005.01021.x","journal-title":"Epilepsia"},{"key":"5464_CR88","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pediatrneurol.2017.07.009","volume":"76","author":"F Al Amrani","year":"2017","unstructured":"Al Amrani F et al (2017) Intravenous immunoglobulin as a treatment for intractable epilepsy secondary to focal cortical dysplasia: a meta-analysis. Pediatr Neurol 76:79\u201381. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.07.009","journal-title":"Pediatr Neurol"},{"key":"5464_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106282","volume":"161","author":"SL Hodges","year":"2020","unstructured":"Hodges SL, Lugo JN (2020) Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy. Epilepsy Res 161:106282. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106282","journal-title":"Epilepsy Res"},{"key":"5464_CR90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-6-38","volume":"6","author":"J Choi","year":"2009","unstructured":"Choi J et al (2009) Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 6:38. https:\/\/doi.org\/10.1186\/1742-2094-6-38","journal-title":"J Neuroinflammation"},{"key":"5464_CR91","doi-asserted-by":"publisher","first-page":"15904","DOI":"10.1038\/s41598-017-16041-w","volume":"7","author":"A Srivastava","year":"2017","unstructured":"Srivastava A et al (2017) Comparative analysis of cytokine\/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD). Sci Rep 7:15904. https:\/\/doi.org\/10.1038\/s41598-017-16041-w","journal-title":"Sci Rep"},{"key":"5464_CR92","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuroscience.2010.02.047","volume":"167","author":"AM Iyer","year":"2010","unstructured":"Iyer AM et al (2010) Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 167:929\u2013945. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.02.047","journal-title":"Neuroscience"},{"key":"5464_CR93","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/brain\/awr032","volume":"134","author":"E Zurolo","year":"2011","unstructured":"Zurolo E et al (2011) Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134:1015\u20131032. https:\/\/doi.org\/10.1093\/brain\/awr032","journal-title":"Brain"},{"key":"5464_CR94","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00401-008-0354-6","volume":"115","author":"K Boer","year":"2008","unstructured":"Boer K et al (2008) Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol 115:683\u2013696. https:\/\/doi.org\/10.1007\/s00401-008-0354-6","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5464_CR95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.25005","volume":"82","author":"L Rossini","year":"2017","unstructured":"Rossini L, Garbelli R, Gnatkovsky V, Didato G, Villani F, Spreafico R, Deleo F, Lo Russo G et al (2017) Seizure activity per se does not induce tissue damage markers in human neocortical focal epilepsy. Ann Neurol 82(3):331\u2013341. https:\/\/doi.org\/10.1002\/ana.25005","journal-title":"Ann Neurol"},{"key":"5464_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2015.02.004","volume":"76","author":"MJ Benson","year":"2015","unstructured":"Benson MJ, Thomas NK, Talwar S, Hodson MP, Lynch JW, Woodruff TM, Borges K (2015) A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models. Neurobiol Dis 76:87\u201397. https:\/\/doi.org\/10.1016\/j.nbd.2015.02.004","journal-title":"Neurobiol Dis"},{"key":"5464_CR97","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5464_CR98","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ana.26644","volume":"94","author":"AE Tipton","year":"2023","unstructured":"Tipton AE, Cruz Del Angel Y, Hixson K, Carlsen J, Strode D, Busquet N, Mesches MH, Gonzalez MI et al (2023) Selective neuronal knockout of STAT3 function inhibits epilepsy progression, improves cognition, and restores dysregulated gene networks in a temporal lobe epilepsy model. Ann Neurol 94(1):106\u2013122. https:\/\/doi.org\/10.1002\/ana.26644","journal-title":"Ann Neurol"},{"key":"5464_CR99","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12974-018-1139-z","volume":"15","author":"CL Han","year":"2018","unstructured":"Han CL et al (2018) LncRNA H19 contributes to hippocampal glial cell activation via JAK\/STAT signaling in a rat model of temporal lobe epilepsy. J Neuroinflammation 15:103. https:\/\/doi.org\/10.1186\/s12974-018-1139-z","journal-title":"J Neuroinflammation"},{"key":"5464_CR100","doi-asserted-by":"publisher","DOI":"10.2174\/0115665240301053240919071840","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Contribution of the activated mTOR-STAT3 pathway to the pathogenesis of focal cortical dysplasia type IIIa in pediatric patients through astrocyte proliferation mediation. Curr Mol Med. https:\/\/doi.org\/10.2174\/0115665240301053240919071840","journal-title":"Curr Mol Med"},{"key":"5464_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151523","volume":"46","author":"K Kumari","year":"2020","unstructured":"Kumari K et al (2020) Mtor pathway activation in focal cortical dysplasia. Ann Diagn Pathol 46:151523. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151523","journal-title":"Ann Diagn Pathol"},{"key":"5464_CR102","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/NEN.0b013e3181eaeae5","volume":"69","author":"HF Shu","year":"2010","unstructured":"Shu HF et al (2010) Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol 69:838\u2013849. https:\/\/doi.org\/10.1097\/NEN.0b013e3181eaeae5","journal-title":"J Neuropathol Exp Neurol"},{"key":"5464_CR103","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/nen.0000000000000042","volume":"73","author":"W Guo","year":"2014","unstructured":"Guo W et al (2014) Expression and cellular distribution of the interleukin 2 signaling system in cortical lesions from patients with focal cortical dysplasia. J Neuropathol Exp Neurol 73:206\u2013222. https:\/\/doi.org\/10.1097\/nen.0000000000000042","journal-title":"J Neuropathol Exp Neurol"},{"key":"5464_CR104","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.1523\/jneurosci.0315-17.2017","volume":"37","author":"DS Tian","year":"2017","unstructured":"Tian DS et al (2017) Chemokine CCL2-CCR2 signaling induces neuronal cell death via STAT3 activation and IL-1\u03b2 production after status epilepticus. J Neurosci 37:7878\u20137892. https:\/\/doi.org\/10.1523\/jneurosci.0315-17.2017","journal-title":"J Neurosci"},{"key":"5464_CR105","doi-asserted-by":"publisher","unstructured":"Han CL, Han C-L, Liu Y-P, Guo C-J, Du T-T, Jiang Y, Wang K-L, Shao X-Q et al (2020) The lncRNA H19 binding to let-7b promotes hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy. Cell Prolif 53(8):e12856. https:\/\/doi.org\/10.1111\/cpr.12856","DOI":"10.1111\/cpr.12856"},{"key":"5464_CR106","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuron.2011.11.024","volume":"73","author":"CS Nicolas","year":"2012","unstructured":"Nicolas CS et al (2012) The Jak\/STAT pathway is involved in synaptic plasticity. Neuron 73:374\u2013390. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.024","journal-title":"Neuron"},{"key":"5464_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413355","author":"TY Postnikova","year":"2021","unstructured":"Postnikova TY et al (2021) Impairments of long-term synaptic plasticity in the hippocampus of young rats during the latent phase of the lithium-pilocarpine model of temporal lobe epilepsy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222413355","journal-title":"Int J Mol Sci"},{"key":"5464_CR108","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL et al (2022) The JAK-STAT pathway at 30: much learned, much more to do. Cell 185:3857\u20133876. https:\/\/doi.org\/10.1016\/j.cell.2022.09.023","journal-title":"Cell"},{"key":"5464_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P et al (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 80:106210. https:\/\/doi.org\/10.1016\/j.intimp.2020.106210","journal-title":"Int Immunopharmacol"},{"key":"5464_CR110","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/jneurosci.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H et al (2016) Inhibition of the JAK\/STAT pathway protects against \u03b1-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36:5144\u20135159. https:\/\/doi.org\/10.1523\/jneurosci.4658-15.2016","journal-title":"J Neurosci"},{"key":"5464_CR111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-023-00380-y","volume":"12","author":"PJ Richardson","year":"2023","unstructured":"Richardson PJ et al (2023) Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. Transl Neurodegener 12:47. https:\/\/doi.org\/10.1186\/s40035-023-00380-y","journal-title":"Transl Neurodegener"},{"key":"5464_CR112","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2174\/1570159x21666221214170234","volume":"21","author":"H Sun","year":"2023","unstructured":"Sun H et al (2023) The JAK-STAT signaling pathway in epilepsy. Curr Neuropharmacol 21:2049\u20132069. https:\/\/doi.org\/10.2174\/1570159x21666221214170234","journal-title":"Curr Neuropharmacol"},{"key":"5464_CR113","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176:1248\u20131264. https:\/\/doi.org\/10.1016\/j.cell.2019.01.021","journal-title":"Cell"},{"issue":"2","key":"5464_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189079","volume":"1879","author":"P Shaw","year":"2024","unstructured":"Shaw P, Dwivedi SKD, Bhattacharya R, Mukherjee P, Rao G (2024) VEGF signaling: role in angiogenesis and beyond. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879(2):189079. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189079","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"5","key":"5464_CR115","doi-asserted-by":"publisher","first-page":"e13065","DOI":"10.1111\/bpa.13065","volume":"32","author":"KF Shen","year":"2022","unstructured":"Shen KF, Shen K-F, Duan Q-T, Duan W, Xu S-L, An N, Ke Y-Y, Wang L-T et al (2022) Vascular endothelial growth factor-C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia. Brain Pathol 32(5):e13065. https:\/\/doi.org\/10.1111\/bpa.13065","journal-title":"Brain Pathol"},{"key":"5464_CR116","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0340-22.2023","author":"M Dusing","year":"2023","unstructured":"Dusing M et al (2023) Neurovascular development in Pten and Tsc2 mouse mutants. eNeuro. https:\/\/doi.org\/10.1523\/eneuro.0340-22.2023","journal-title":"eNeuro"},{"issue":"9","key":"5464_CR117","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/mcb.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16(9):4604\u20134613. https:\/\/doi.org\/10.1128\/mcb.16.9.4604","journal-title":"Mol Cell Biol"},{"key":"5464_CR118","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/epi.15969","volume":"60","author":"L Zhang","year":"2019","unstructured":"Zhang L, Huang T, Teaw S, Bordey A (2019) Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity. Epilepsia 60:1255\u20131265. https:\/\/doi.org\/10.1111\/epi.15969","journal-title":"Epilepsia"},{"key":"5464_CR119","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2015.11.038","volume":"612","author":"L Zhang","year":"2016","unstructured":"Zhang L, Feliciano DM, Huang T, Zhang S, Bordey A (2016) Hypoxia-inducible factor-1a contributes to dendritic overgrowth in tuberous sclerosis. Neurosci Lett 612:43\u201347. https:\/\/doi.org\/10.1016\/j.neulet.2015.11.038","journal-title":"Neurosci Lett"},{"key":"5464_CR120","doi-asserted-by":"publisher","first-page":"38205","DOI":"10.1074\/jbc.M203781200","volume":"277","author":"R Fukuda","year":"2002","unstructured":"Fukuda R et al (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205\u201338211. https:\/\/doi.org\/10.1074\/jbc.M203781200","journal-title":"J Biol Chem"},{"key":"5464_CR121","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732. https:\/\/doi.org\/10.1038\/nrc1187","journal-title":"Nat Rev Cancer"},{"key":"5464_CR122","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR (2015) mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34:2239\u20132250. https:\/\/doi.org\/10.1038\/onc.2014.164","journal-title":"Oncogene"},{"key":"5464_CR123","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2010.06.080","volume":"398","author":"CX Bian","year":"2010","unstructured":"Bian CX et al (2010) P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression. Biochem Biophys Res Commun 398:395\u2013399. https:\/\/doi.org\/10.1016\/j.bbrc.2010.06.080","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"5464_CR124","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ctrv.2015.06.008","volume":"41","author":"CA Cella","year":"2015","unstructured":"Cella CA, Minucci S, Spada F, Galdy S, Elgendy M, Ravenda PS, Zampino MG, Murgioni S et al (2015) Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside. Cancer Treat Rev 41(9):754\u2013760. https:\/\/doi.org\/10.1016\/j.ctrv.2015.06.008","journal-title":"Cancer Treat Rev"},{"key":"5464_CR125","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/epi.17848","volume":"65","author":"D Guo","year":"2024","unstructured":"Guo D, Zhang B, Han L, Rensing NR, Wong M (2024) Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex. Epilepsia 65:483\u2013496. https:\/\/doi.org\/10.1111\/epi.17848","journal-title":"Epilepsia"},{"key":"5464_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.808568","volume":"12","author":"W Han","year":"2021","unstructured":"Han W et al (2021) VEGF modulates neurogenesis and microvascular remodeling in epileptogenesis after status epilepticus in immature rats. Front Neurol 12:808568. https:\/\/doi.org\/10.3389\/fneur.2021.808568","journal-title":"Front Neurol"},{"key":"5464_CR127","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.08.046","volume":"342","author":"X Li","year":"2014","unstructured":"Li X, Tong LJ, Ding J, Meng LH (2014) Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer. Cancer Lett 342:159\u2013166. https:\/\/doi.org\/10.1016\/j.canlet.2013.08.046","journal-title":"Cancer Lett"},{"key":"5464_CR128","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nm1337","volume":"12","author":"GV Thomas","year":"2006","unstructured":"Thomas GV et al (2006) Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 12:122\u2013127. https:\/\/doi.org\/10.1038\/nm1337","journal-title":"Nat Med"},{"key":"5464_CR129","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","volume":"185","author":"CS Wang","year":"2022","unstructured":"Wang CS, Kavalali ET, Monteggia LM (2022) BDNF signaling in context: from synaptic regulation to psychiatric disorders. Cell 185:62\u201376. https:\/\/doi.org\/10.1016\/j.cell.2021.12.003","journal-title":"Cell"},{"key":"5464_CR130","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2990.1999.00180.x","volume":"25","author":"S Nishio","year":"1999","unstructured":"Nishio S, Morioka T, Hamada Y, Hisada K, Fukui M (1999) Immunohistochemical expression of trk receptor proteins in focal cortical dysplasia with intractable epilepsy. Neuropathol Appl Neurobiol 25:188\u2013195. https:\/\/doi.org\/10.1046\/j.1365-2990.1999.00180.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5464_CR131","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00401-004-0906-3","volume":"108","author":"E Aronica","year":"2004","unstructured":"Aronica E et al (2004) Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol 108:422\u2013434. https:\/\/doi.org\/10.1007\/s00401-004-0906-3","journal-title":"Acta Neuropathol"},{"key":"5464_CR132","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5414\/np301026","volume":"36","author":"F Wang","year":"2017","unstructured":"Wang F et al (2017) Distribution and expression of brain-derived neurotrophic factor, nerve growth factor, and neurotrophic factor-3 in refractory epilepsy-associated focal cortical dysplasia. Clin Neuropathol 36:233\u2013239. https:\/\/doi.org\/10.5414\/np301026","journal-title":"Clin Neuropathol"},{"key":"5464_CR133","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/jnen\/nlw044","volume":"75","author":"DH Zheng","year":"2016","unstructured":"Zheng DH et al (2016) Expression of TRPC6 and BDNF in cortical lesions from patients with focal cortical dysplasia. J Neuropathol Exp Neurol 75:718\u2013730. https:\/\/doi.org\/10.1093\/jnen\/nlw044","journal-title":"J Neuropathol Exp Neurol"},{"key":"5464_CR134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2011.01.001","volume":"42","author":"C Heinrich","year":"2011","unstructured":"Heinrich C et al (2011) Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy. Neurobiol Dis 42:35\u201347. https:\/\/doi.org\/10.1016\/j.nbd.2011.01.001","journal-title":"Neurobiol Dis"},{"key":"5464_CR135","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s40478-024-01897-7","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Spatial transcriptomics in focal cortical dysplasia type IIb. Acta Neuropathol Commun 12:185. https:\/\/doi.org\/10.1186\/s40478-024-01897-7","journal-title":"Acta Neuropathol Commun"},{"key":"5464_CR136","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41593-025-01936-z","volume":"28","author":"S Baldassari","year":"2025","unstructured":"Baldassari S et al (2025) Single-cell genotyping and transcriptomic profiling of mosaic focal cortical dysplasia. Nat Neurosci 28:964\u2013972. https:\/\/doi.org\/10.1038\/s41593-025-01936-z","journal-title":"Nat Neurosci"},{"key":"5464_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111337","volume":"27","author":"IC Galv\u00e3o","year":"2024","unstructured":"Galv\u00e3o IC et al (2024) Multimodal single-cell profiling reveals neuronal vulnerability and pathological cell states in focal cortical dysplasia. iScience 27:111337. https:\/\/doi.org\/10.1016\/j.isci.2024.111337","journal-title":"iScience"},{"key":"5464_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1566137","volume":"13","author":"Y Zhang","year":"2025","unstructured":"Zhang Y et al (2025) Critical contributions of neuronal subtypes to pediatric drug-resistant focal dysplasia. Front Cell Dev Biol 13:1566137. https:\/\/doi.org\/10.3389\/fcell.2025.1566137","journal-title":"Front Cell Dev Biol"},{"issue":"09","key":"5464_CR139","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5414\/np301214","volume":"38","author":"V Gruber","year":"2019","unstructured":"Gruber V, Scholl T, Samueli S, Gr\u00f6ppel G, M\u00fchlebner A, Hainfellner JA, Feucht M (2019) Pathophysiology of neurodevelopmental mTOR pathway-associated epileptic conditions: current status of biomedical research. Clin Neuropathol 38(09):210\u2013224. https:\/\/doi.org\/10.5414\/np301214","journal-title":"Clin Neuropathol"},{"key":"5464_CR140","doi-asserted-by":"publisher","first-page":"100483","DOI":"10.1016\/j.xhgg.2025.100483","volume":"6","author":"N \u017dakelj","year":"2025","unstructured":"\u017dakelj N et al (2025) Genotypic, functional, and phenotypic characterization in CTNNB1 neurodevelopmental syndrome. HGG Adv 6:100483. https:\/\/doi.org\/10.1016\/j.xhgg.2025.100483","journal-title":"HGG Adv"},{"key":"5464_CR141","doi-asserted-by":"publisher","first-page":"1522079","DOI":"10.3389\/fped.2024.1522079","volume":"12","author":"L Zhu","year":"2024","unstructured":"Zhu L, Xia Y, Ding H, Zhang T, Li J, Li B (2024) Infantile epileptic spasms syndrome: an etiologic study of 361 patients with infantile epileptic spasms syndrome. Front Pediatr 12:1522079. https:\/\/doi.org\/10.3389\/fped.2024.1522079","journal-title":"Front Pediatr"},{"issue":"1","key":"5464_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0178-0","volume":"8","author":"AM Kolesnik","year":"2017","unstructured":"Kolesnik AM, Jones EJH, Garg S, Green J, Charman T, Johnson MH (2017) Early development of infants with neurofibromatosis type 1: a case series. Mol Autism 8(1):62. https:\/\/doi.org\/10.1186\/s13229-017-0178-0","journal-title":"Mol Autism"},{"key":"5464_CR143","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1038\/s41467-025-58535-6","volume":"16","author":"C Fang","year":"2025","unstructured":"Fang C et al (2025) Transcriptomic and morphologic vascular aberrations underlying FCDIIb etiology. Nat Commun 16:3320. https:\/\/doi.org\/10.1038\/s41467-025-58535-6","journal-title":"Nat Commun"},{"issue":"2","key":"5464_CR144","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ana.26149","volume":"90","author":"HY Koh","year":"2021","unstructured":"Koh HY, Jang J, Ju SH, Kim R, Cho G-B, Kim DS, Sohn J-W, Paik S-B et al (2021) Non-cell autonomous epileptogenesis in focal cortical dysplasia. Ann Neurol 90(2):285\u2013299. https:\/\/doi.org\/10.1002\/ana.26149","journal-title":"Ann Neurol"},{"key":"5464_CR145","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nm.3982","volume":"21","author":"ST Baek","year":"2015","unstructured":"Baek ST et al (2015) An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. Nat Med 21:1445\u20131454. https:\/\/doi.org\/10.1038\/nm.3982","journal-title":"Nat Med"},{"key":"5464_CR146","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.ajhg.2024.09.006","volume":"111","author":"M Gong","year":"2024","unstructured":"Gong M et al (2024) MARK2 variants cause autism spectrum disorder via the downregulation of WNT\/\u03b2-catenin signaling pathway. Am J Hum Genet 111:2392\u20132410. https:\/\/doi.org\/10.1016\/j.ajhg.2024.09.006","journal-title":"Am J Hum Genet"},{"key":"5464_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109682","volume":"239","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) The Notch1\/Hes1 signaling pathway affects autophagy by adjusting DNA methyltransferases expression in a valproic acid-induced autism spectrum disorder model. Neuropharmacology 239:109682. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109682","journal-title":"Neuropharmacology"},{"key":"5464_CR148","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1152\/physrev.00038.2024","volume":"105","author":"YA Barde","year":"2025","unstructured":"Barde YA (2025) The physiopathology of brain-derived neurotrophic factor. Physiol Rev 105:2073\u20132140. https:\/\/doi.org\/10.1152\/physrev.00038.2024","journal-title":"Physiol Rev"},{"key":"5464_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111678","volume":"41","author":"N Murtaza","year":"2022","unstructured":"Murtaza N et al (2022) Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies. Cell Rep 41:111678. https:\/\/doi.org\/10.1016\/j.celrep.2022.111678","journal-title":"Cell Rep"},{"key":"5464_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.754296","volume":"8","author":"H Sabaie","year":"2021","unstructured":"Sabaie H et al (2021) Mechanistic insight into the regulation of immune-related genes expression in autism spectrum disorder. Front Mol Biosci 8:754296. https:\/\/doi.org\/10.3389\/fmolb.2021.754296","journal-title":"Front Mol Biosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05464-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T19:03:13Z","timestamp":1764097393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05464-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5464"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05464-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Considerations."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"171"}}